During August’s initial days, the chief of a popular private Chinese organization revealed a good news to his staff. He told them that a Chinese vaccine for coronavirus might arrive in the market by November 2020.
The organization mentioned above has its healthcare division. In this context, the boss revealed that the vaccine is a potential way to recover all the economic losses that they have faced recently.
Once the Chinese vaccine hits the markets, it will have a huge sale. That’s why the government of China agreed not to delay the announcement.
The origin of the novel coronavirus that further gave way to the global pandemic is China itself. Later, the infection spread across the world, leaving no country devoid of cases. Therefore, the government is now cashing on its global reputation; to achieve victory in the race of discovering a vaccine first.
Besides, they will create history if the Chinese vaccine’s deployment takes place before any other country. A couple of days back, pictures of a developmental vaccine started doing the rounds in the local news channels. Moreover, there was a picture of a smiling woman holding the vaccine. The design of the box was also visible from the ads.
Cost and features of expected Chinese vaccine for coronavirus
During an interview, the spokesperson of Sinopharm says that they were hopeful of getting the vaccine ready by the end of the year. They also quoted an approximate price of the vaccine that will be around £106 or $140.
China’s determination is crossing every boundary. The country even claims that presently all the six vaccine samples undergoing the final testing process are developed in China. The global trials are mandatory, and China is awaiting the results.
The irony is that the Chinese vaccine cannot be tested in their own country because it won’t be possible on a large scale. Moreover, testing is not possible because China has successfully controlled the virus’s spread within its borders.
According to Professor Ben Cowling of the Hong Kong University of Public Health, every vaccine manufacturer is looking for proper areas for large-scale vaccine testing. During Phase-3 testing, the vaccine has to be applied to more than a thousand people. However, the testing procedure can only be successfully done in an area where the rate of circulation is comparatively more.
China is moving ahead of all other nations in the vaccine race
Professor Cowling says that he is hopeful for big success from the developmental procedure of the vaccines. He believes that all the vaccines that are undergoing the phase-3 tests have great potential of becoming effective.
A couple of days back, one senior Chinese medical officer spilled the beans partially. He said that vaccine testing in China had become a rigorous process. Scientists and medical experts were applying the probable vaccines on essential public workers since July.
National Health Commission member Zheng Zhongwei reveals in an interview that officials cannot use anyone randomly for the testing. He added that the government has strictly prohibited the testing of a Chinese vaccine on any random person. However, they are okay with the medicine application on border officials and similar essential people.
Professor Cowling believes that being first to launch a vaccine won’t be of any use if the effect of the same is not stable. Also, enough supply of the vaccine is essential. He says that there are high chances of several vaccines coming to the market by the end of 2020. However, he doubts whether the supply will be enough to satisfy the global requirement.
Progress in phase-3 vaccine testing
According to Professor Cowling, the vaccination will reach a steady position only by summer 2021. By then, there are possibilities that the maximum people will get immunized. While there are several verification levels, China’s government confirms that its vaccine is already undergoing advanced trials.
The scientists are applying the developmental vaccine on numerous people across the UAE, Argentina, and Peru. Now, the procedure is a significant part of the official global collaborations between pharmaceutical firms and governments.
Presently, there are cases of unpublicized testing too. Recently, a bunch of Chinese minors was not able to enter Papua New Guinea after their employer said it was utilizing them for antibody testing.
According to the reports from the Chinese government company running the mine in the Pacific Islands country, around 48 workers received vaccination at the beginning of August. The PNG officials are doubtful that they are living in the dark. It means that they believe some of the workers undergoing the prelims may have tested for COVID-19.
Is a Chinese vaccine the face of a giant conspiracy?
There is uncertainty about what China will do with the antibody if and when it has it. The English language adaptation of the official government report into how China is handling the outbreak expresses that they want to use the Covid-19 immunization as a worldwide public item once the creation and deployment is over.
The country further highlights that nations in Africa and its close neighbors in South East Asia would be the first to profit by a Chinese-created antibody when it has been deployed in China.
On the contrary, some experts are sensing discretionary influence at play. One senior European negotiator highlighted what they saw as China’s awkward propaganda efforts during its “mask diplomacy” in Italy and Serbia, where it had delivered health kits as soon as the outbreak intensified.
Political diplomats and experts are warning governments of other countries. Besides, the vaccine race of China may be a rather calculative move. The reason for such strategies is nothing but gaining a more robust position globally. The dedication to helping people worldwide with a vaccine can be a part of a bigger game.